IMPACTS OF BLOOD GLUCOSE CONTROL WITH NOVEL DIABETIC DRUGS ON MAJOR ADVERSE CARDIOVASCULAR EVENTS: META-REGRESSION ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
2018
Until recently, type 2 diabetes (T2D) therapies other than metformin had little obvious favorable effect on cardiovascular (CV) outcomes. With the availability of many novel armaments, their overall effects of blood glucose control on cardiovascular outcome remains unclear.
To investigate the
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI